ACT EU aims to provide a training curriculum informed by regulatory experience, with modules on drug development and regulatory science.
This curriculum is expected to engage universities and small and medium-sized enterprises, and serve as an educational ecosystem.
Related documents
A training strategy is available, setting out high-level objectives for the development of a training curriculum. The document highlights the importance of accessing appropriate expertise in medicines development.
A summary of the gap analysis on training needs of regulators involved in clinical trial assessment is also available.
